Baksh, Sheriza
Wen, Jiajun
Mansour, Omar
Chang, Hsien-Yen
McAdams-DeMarco, Mara
Segal, Jodi B.
Ehrhardt, Stephan
Alexander, G. Caleb
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (T32HL139426)
U.S. Food and Drug Administration (U01FD004977-03)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK120518)
Article History
Received: 2 April 2021
Accepted: 26 July 2021
First Online: 17 August 2021
Competing interests
: Dr. Alexander is Chair of FDA’s Peripheral and Central Nervous System Advisory Committee, has served as a paid advisor to IQVIA, is a co-founding Principal and equity holder in Monument Analytics, a health care consultancy whose clients include the life sciences industry as well as plaintiffs in opioid litigation, and serves on OptumRx’s National P&T Committee. This arrangement has been reviewed and approved by Johns Hopkins University in accordance with its conflict of interest policies. All other authors have no conflict of interest.